Inducible nitric oxide synthase in obesity-associated insulin resistance: tissue-specific mechanisms and emerging metabolic roles
Molecular and Cellular Endocrinology · 2026-11 · 112953
DOI: 10.1016/j.mce.2026.112953 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular and Cellular Endocrinology, 2026-11. Verfasst von Tamires M Zanotto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, SP, Brazil; Department of Medical Clinics, Obesity and Comorbiditi…. Die Arbeit nennt 66 Literaturangaben.
Abstract (Originalsprache)
Obesity-associated insulin resistance develops through a complex interplay of nutrient excess, chronic low-grade inflammation, cellular stress, and impaired communication among metabolically active tissues. Inducible nitric oxide synthase (iNOS), encoded by NOS2, can contribute to metabolic dysfunction through sustained nitric oxide (NO) production and nitrosative modifications that impair insulin signaling in skeletal muscle and liver and promote inflammatory remodeling of adipose tissue. Evidence predominantly from rodent models also links iNOS to endoplasmic reticulum stress, with metabolic effects varying according to cell type, tissue, and experimental context. Recent evidence indicates that iNOS deficiency is associated with changes in gut microbiota, altered expression patterns of genes associated with intestinal tight junctions, and altered adipose tissue inflammation. Importantly, fecal microbiota transplantation studies provide functional evidence that iNOS-associated alterations in the gut microbiota contribute to the metabolic phenotype. Emerging in vitro evidence also identifies an NO-independent interaction between iNOS and mitochondrial IRG1, although its relevance to obesity-associated insulin resistance remains unproven. By integrating NO-dependent and emerging NO-independent mechanisms across muscle, liver, adipose tissue, and the intestine, this narrative review highlights the context-dependent metabolic roles of iNOS and discusses the therapeutic potential and limitations of targeting iNOS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, SP, Brazil; Department of Medical Clinics, Obesity and Comorbidities Research Center (O.C.R.C.), State University of Campinas (UNICAMP),…
Zitieren
APA
Zanotto, T. M., & Saad, M. J. A. (2026). Inducible nitric oxide synthase in obesity-associated insulin resistance: tissue-specific mechanisms and emerging metabolic roles. Molecular and Cellular Endocrinology, 112953. https://doi.org/10.1016/j.mce.2026.112953
Vancouver
Zanotto TM, Saad MJA. Inducible nitric oxide synthase in obesity-associated insulin resistance: tissue-specific mechanisms and emerging metabolic roles. Molecular and Cellular Endocrinology. 2026:112953. doi:10.1016/j.mce.2026.112953
BibTeX
@article{Zanotto2026,
author = {Zanotto, Tamires M and Saad, Mario J A},
title = {Inducible nitric oxide synthase in obesity-associated insulin resistance: tissue-specific mechanisms and emerging metabolic roles},
journal = {Molecular and Cellular Endocrinology},
year = {2026},
pages = {112953},
doi = {10.1016/j.mce.2026.112953}
}
EUVIMED